More about

Stroke

News
July 05, 2024
3 min read
Save

Statin use when not indicated for certain strokes could cause adverse events

Statin use when not indicated for certain strokes could cause adverse events

Statin initiation in patients with stroke etiologies not indicated for secondary prevention with statin therapy could hypothetically cause thousands of adverse events every year, according to a new meta-analysis published in Stroke.

News
June 28, 2024
2 min read
Save

Study: Chronic loneliness increases stroke risk in middle-aged, older adults

Study: Chronic loneliness increases stroke risk in middle-aged, older adults

Loneliness was associated with an increased risk for stroke in middle-aged and older adults, and the risk was particularly high among those with chronic loneliness, a study in eClinicalMedicine showed.

News
June 10, 2024
2 min read
Save

Low eGFR linked to high mortality rate but not to cardiovascular events in older patients

Low eGFR linked to high mortality rate but not to cardiovascular events in older patients

Among older adults participating in the Systolic Blood Pressure Intervention Trial, a low eGFR without albuminuria was associated with a higher mortality rate but not with increased risk of cardiovascular events, results showed.

News
June 06, 2024
3 min read
Save

Common sugar substitute facilitates blood clotting, raising risk for heart attack, stroke

Common sugar substitute facilitates  blood clotting, raising risk for heart attack, stroke

Xylitol, a low-calorie sugar substitute commonly found in gum and toothpaste, demonstrated prothrombotic properties, possibly raising risk for major adverse CV events, researchers reported.

News
June 04, 2024
4 min read
Save

Prevalence, economic burden of heart disease, stroke likely to rise greatly in US by 2050

Prevalence, economic burden of heart disease, stroke likely to rise greatly in US by 2050

Due to demographic changes and a rise in risk factors, the prevalence and economic burden of heart disease and stroke in the United States are expected to increase dramatically by 2050, according to the American Heart Association.

News
June 02, 2024
2 min read
Save

Single excess weight measurement ‘does not seal one’s fate’ for heart-related events

Single excess weight measurement ‘does not seal one’s fate’ for heart-related events

BOSTON — Younger adults are at greater cardiovascular disease risk if they have obesity for 10 years, but a single excess weight measurement does not predict risk for heart-related events over time, according to data presented at ENDO 2024.

News
May 31, 2024
1 min read
Save

Adults with class II to III obesity may have increased cardiac outcomes

Adults with class II to III obesity may have increased cardiac outcomes

Adults with class II to III obesity may have an increased risk for poor cardiac outcomes but not kidney risk after adjusting for potential confounders, according to multicenter data.

News
May 30, 2024
1 min read
Save

FDA grants 510(k) clearance to CT imaging analysis solution for intracerebral hemorrhage

FDA grants 510(k) clearance to CT imaging analysis solution for intracerebral hemorrhage

The FDA has granted 510(k) clearance to a South Korea-based specialized medical AI startup for its non-contrast CT imaging analysis solution to detect intracerebral hemorrhage.

News
May 29, 2024
2 min read
Save

Regular fish oil use may pose cardiovascular risk in those with no prior CVD

Regular fish oil use may pose cardiovascular risk in those with no prior CVD

Regular use of fish oil supplements was tied to an increased risk of stroke and atrial fibrillation in adults with no prior CVD, according to results of a large prospective cohort study published in BMJ Medicine.

News
May 28, 2024
2 min read
Save

Study: Semaglutide slowed progression of CKD, cut cardiovascular events, mortality risk

Study: Semaglutide slowed progression of CKD, cut cardiovascular events, mortality risk

Use of the drug semaglutide in patients with type 2 diabetes significantly reduced the risk of major kidney disease events, cardiovascular outcomes and all-cause mortality vs. placebo, newly published data show.

View more